Literature DB >> 11258576

Analysis of ambulatory duodenogastroesophageal reflux monitoring.

R Cuomo1, G Koek, D Sifrim, J Janssens, J Tack.   

Abstract

Some methodological in vitro observations concerning bile reflux monitoring (Bilitec) suggested that Bilitec monitoring is underestimating reflux in an acid environment. Moreover, other studies showed that the area above the cutoff level of bilirubin absorbance would provide an adequate quantitative marker for reflux of duodenal contents. Our aim was to study whether correction for intraesophageal acidity and the area above cutoff during Bilitec monitoring affects the results and the correlation with pH measurement and esophageal lesions. In 84 patients (46 men; mean age 46 +/- 2.7 years) evaluated for suspected gastroesophageal reflux disease, we performed ambulatory 24-hr esophageal pH and Bilitec monitoring after an upper gastrointestinal endoscopy. We obtained total area, percent total time, and correction by computer software. The correction factor for bilirubin absorbance was based on literature data for acidified bile (0.06 for pH < 3.6; 0.21 for pH < 2.6). Endoscopy revealed esophagitis grade 1-2 (E1-2) and 3-4 (E3-4) in 23 and 16 patients, respectively. A progressive increase of mixed (acid + bile) reflux occurred with increasing severity of endoscopic lesions (E3-4 vs no esophagitis, P < 0.05). A pathologic Bilitec monitoring result was present in the same 35 patients before and after correction and the correlation between the pH measurement and percent time of bile reflux was not improved by correction for intraesophageal pH (r = 0.386 and r = 0.391; P < 0.05). The total area of bilirubin absorbance above 0.14 (abs x min) was 7.8 +/- 2.2 in patients without esophagitis, and 11.7 +/- 4.4 and 17.0 +/- 4.2 in the E1-2 and E3-4 groups, respectively (E3-4 vs no esophagitis, P < 0.05). The correlation between the Bilitec monitoring and pH measurement regarding percent (r = 0.427, P < 0.01) or area of time below 4 (r = 0.280, P < 0.05) was not improved by considering the area of bilirubin absorbance above the cutoff level. Correction for intraesophageal pH has only a minor effect on the results of ambulatory Bilitec monitoring. Taking into account the surface rather than the percent of time above the cutoff level for bilirubin absorbance does not improve the correlation of Bilitec with acid reflux and with esophageal lesions.

Entities:  

Mesh:

Year:  2000        PMID: 11258576     DOI: 10.1023/a:1005667731289

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  The temporal relationship between oesophageal bile reflux and pH in gastro-oesophageal reflux disease.

Authors:  R E Marshall; A Anggiansah; W A Owen; W J Owen
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-05       Impact factor: 2.566

2.  Scintigraphic evaluation of duodenogastric reflux. Problems, pitfalls, and technical review.

Authors:  W E Drane; K Karvelis; D A Johnson; E D Silverman
Journal:  Clin Nucl Med       Date:  1987-05       Impact factor: 7.794

3.  An ambulatory bile reflux monitoring system: an in vitro appraisal.

Authors:  M T Caldwell; P J Byrne; N Brazil; V Crowley; S E Attwood; T N Walsh; T P Hennessy
Journal:  Physiol Meas       Date:  1994-02       Impact factor: 2.833

4.  Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique.

Authors:  P Bechi; F Pucciani; F Baldini; F Cosi; R Falciai; R Mazzanti; A Castagnoli; A Passeri; S Boscherini
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

5.  The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease.

Authors:  R E Marshall; A Anggiansah; W A Owen; W J Owen
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

6.  Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring.

Authors:  F Stipa; H J Stein; H Feussner; S Kraemer; J R Siewert
Journal:  Dis Esophagus       Date:  1997-01       Impact factor: 3.429

7.  Bile salts in the esophagus of patients with esophagitis.

Authors:  F Johnsson; B Joelsson; C H Florén; A Nilsson
Journal:  Scand J Gastroenterol       Date:  1988-08       Impact factor: 2.423

8.  Determinants of oesophageal 'alkaline' pH environment in controls and patients with gastro-oesophageal reflux disease.

Authors:  S Singh; L A Bradley; J E Richter
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Bile acid concentrations in the refluxate of patients with reflux oesophagitis.

Authors:  D C Gotley; A P Morgan; M J Cooper
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

10.  Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus.

Authors:  S E Attwood; T R DeMeester; C G Bremner; A P Barlow; R A Hinder
Journal:  Surgery       Date:  1989-10       Impact factor: 3.982

View more
  14 in total

1.  Assessment of duodenogastric reflux by combined continuous intragastric pH and bilirubin monitoring.

Authors:  Fei Dai; Jun Gong; Ru Zhang; Jin-Yan Luo; You-Ling Zhu; Xue-Qin Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux.

Authors:  Jan Tack; Raf Bisschops; Gerardus Koek; Daniel Sifrim; Tony Lerut; Jozef Janssens
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Duodenogastric reflux after esophagectomy and gastric pull-up: the effect of the route of reconstruction.

Authors:  Iraklis E Katsoulis; Ioannis Robotis; Grigorios Kouraklis; Panagiotis Yannopoulos
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

4.  Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Authors:  Jun Zhang; Pei-Lin Cui; Dong Lv; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

5.  Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.

Authors:  G H Koek; D Sifrim; T Lerut; J Janssens; J Tack
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Comparative evaluation of intragastric bile acids and hepatobiliary scintigraphy in the diagnosis of duodenogastric reflux.

Authors:  Teng-Fei Chen; Praveen K Yadav; Rui-Jin Wu; Wei-Hua Yu; Chang-Qin Liu; Hui Lin; Zhan-Ju Liu
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

7.  Role of duodenogastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms.

Authors:  Xiao-rong Xu; Zhao-shen Li; Duo-wu Zou; Guo-ming Xu; Ping Ye; Zhen-xing Sun; Qing Wang; Yan-jun Zeng
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

8.  A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents.

Authors:  Tao Zhang; Feng Zhang; Yong Han; Zhongping Gu; Yong'an Zhou; Qingshu Cheng; Yifang Zhu; Chuanshan Zhang; Yunjie Wang
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

Review 9.  Barrett's oesophagus: optimal strategies for prevention and treatment.

Authors:  Ronnie Fass; Richard E Sampliner
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Increased prevalence of gallstone disease and impaired gallbladder motility in patients with Barrett's esophagus.

Authors:  Ferenc Izbéki; András I Rosztóczy; John Sebit Yobuta; Richárd Róka; János Lonovics; Tibor Wittmann
Journal:  Dig Dis Sci       Date:  2007-12-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.